Epigenetic Repair of Terrifying Lucid Dreams by Enhanced Brain Reward Functional Connectivity and Induction of Dopaminergic Homeostatic Signaling.
Current psychopharmacology February 15, 2021 Kenneth Blum, Thomas Mclaughlin, Edward J Modestino et al. 9 citations
Terrifying lucid dreams—where the dreamer is aware and may control the dream—can plague patients with Reward Deficiency Syndrome (RDS), including those with ADHD, Tourette's syndrome, and PTSD. In eight clinical cases with histories of substance abuse, childhood abuse, and PTSD, administration of the neuronutrient KB200Z eliminated unpleasant or terrifying lucid dreams in 87.5% of cases. Other published cases have since shown long-term elimination of terrifying dreams in PTSD and ADHD patients. The article proposes that inducing dopamine homeostasis through such neuronutrients may mitigate neurogenetic and epigenetic changes in neuroplasticity underlying these disorders, and that precision formulations guided by Genetic Addiction Risk Score (GARS) testing may repair inheritable brain reward circuitry deficiencies, improving cognitive recall and attenuating trauma's harmful epigenetic insults.